TY - JOUR
T1 - γ-aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression
AU - Shen, Qiuying
AU - Lal, Rachnanjali
AU - Luellen, Beth A.
AU - Earnheart, John C.
AU - Andrews, Anne Milasincic
AU - Luscher, Bernhard
N1 - Funding Information:
We are grateful to Trent Gaugler, Department of Statistics at Penn State, for advice with statistical analyses and to Yao Guo and Ashly Stull for technical assistance. This publication was made possible by Grants MH62391 and MH60989 from the National Institutes of Mental Health (NIMH) and a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the NIMH or the National Institutes of Health. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions.
PY - 2010/9/15
Y1 - 2010/9/15
N2 - Background: The γ-aminobutyric acid (GABA) Type A receptor deficits that are induced by global or forebrain-specific heterozygous inactivation of the γ2 subunit gene in mouse embryos result in behavior indicative of trait anxiety and depressive states. By contrast, a comparable deficit that is delayed to adolescence is without these behavioral consequences. Here we characterized γ2-deficient mice with respect to hypothalamic-pituitary- adrenal (HPA) axis abnormalities and antidepressant drug responses. Methods: We analyzed the behavioral responses of γ2+/- mice to desipramine and fluoxetine in novelty suppressed feeding, forced swim, tail suspension, and sucrose consumption tests as well as GABAA receptor deficit- and antidepressant drug treatment-induced alterations in serum corticosterone. Results: Baseline corticosterone concentrations in adult γ2-deficient mice were elevated independent of whether the genetic lesion was induced during embryogenesis or delayed to adolescence. However, the manifestation of anxious-depressive behavior in different γ2-deficient mouse lines was correlated with early onset HPA axis hyperactivity during postnatal development. Chronic but not subchronic treatment of γ2+/- mice with fluoxetine or desipramine normalized anxiety-like behavior in the novelty suppressed feeding test. Moreover, desipramine had antidepressant-like effects in that it normalized HPA axis function and depression-related behavior of γ2+/- mice in the forced swim, tail suspension, and sucrose consumption tests. By contrast, fluoxetine was ineffective as an antidepressant and failed to normalize HPA axis function. Conclusions: Developmental deficits in GABAergic inhibition in the forebrain cause behavioral and endocrine abnormalities and selective antidepressant drug responsiveness indicative of anxious-depressive disorders such as melancholic depression, which are frequently characterized by HPA axis hyperactivity and greater efficacy of desipramine versus fluoxetine.
AB - Background: The γ-aminobutyric acid (GABA) Type A receptor deficits that are induced by global or forebrain-specific heterozygous inactivation of the γ2 subunit gene in mouse embryos result in behavior indicative of trait anxiety and depressive states. By contrast, a comparable deficit that is delayed to adolescence is without these behavioral consequences. Here we characterized γ2-deficient mice with respect to hypothalamic-pituitary- adrenal (HPA) axis abnormalities and antidepressant drug responses. Methods: We analyzed the behavioral responses of γ2+/- mice to desipramine and fluoxetine in novelty suppressed feeding, forced swim, tail suspension, and sucrose consumption tests as well as GABAA receptor deficit- and antidepressant drug treatment-induced alterations in serum corticosterone. Results: Baseline corticosterone concentrations in adult γ2-deficient mice were elevated independent of whether the genetic lesion was induced during embryogenesis or delayed to adolescence. However, the manifestation of anxious-depressive behavior in different γ2-deficient mouse lines was correlated with early onset HPA axis hyperactivity during postnatal development. Chronic but not subchronic treatment of γ2+/- mice with fluoxetine or desipramine normalized anxiety-like behavior in the novelty suppressed feeding test. Moreover, desipramine had antidepressant-like effects in that it normalized HPA axis function and depression-related behavior of γ2+/- mice in the forced swim, tail suspension, and sucrose consumption tests. By contrast, fluoxetine was ineffective as an antidepressant and failed to normalize HPA axis function. Conclusions: Developmental deficits in GABAergic inhibition in the forebrain cause behavioral and endocrine abnormalities and selective antidepressant drug responsiveness indicative of anxious-depressive disorders such as melancholic depression, which are frequently characterized by HPA axis hyperactivity and greater efficacy of desipramine versus fluoxetine.
UR - http://www.scopus.com/inward/record.url?scp=77956118577&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956118577&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2010.04.024
DO - 10.1016/j.biopsych.2010.04.024
M3 - Article
C2 - 20579975
AN - SCOPUS:77956118577
SN - 0006-3223
VL - 68
SP - 512
EP - 520
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 6
ER -